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Abstract 
Background:  To study the effects  of pro-kinetic 
agents on  post-prandial glycaemia in type 2 diabetes 
mellitus. 
Methods :In this comparative study one hundred 
and eighty patients with Type 2 diabetes mellitus 
and features of gastroparesis were randomly  
recruited. They were divided randomly into two 
groups of ninety each.Group I was given oral anti-
diabetic  agents  and  placebo.  Group II was given 
oral anti-diabetic agents along with domperidone.  
Mean levels  of glycaemic difference. Difference 
between Premeal and two hours postmeal and 
glycaemic levels   were determined  and compared  in 
the two groups. 
Results :Mean fasting blood sugar of Group I was 
168.57 mg/dl and 2 hours postprandial was 296.73 
mg/dl. In Group II mean fasting blood sugar was 
201.24 mg/dl and mean 2 hours postprandial blood 
sugar was 296.42 mg/dl. Mean difference in fasting 
and 2 hours post prandial was 156.38 mg/dl and 
114.15 mg/dl, respectively in Group I and II. 
Conclusion:  Mean difference between fasting and 
2 hours postprandial blood sugar is significantly low 
in patients taking prokinetic drugs, as compared to 
the diabetics not taking pro-kinetic drugs.  
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Introduction 
    Gastric emptying is delayed in majority of patients 
with diabetes.This results in delayed delivery  of 
macronutrients to intestine resulting in diminished 
incretin effect.As a result there is high post prandial 
glucose surge. Augumenting the gastric motility by the 
use of prokinetics optimises incretin secretion and 
decreases the post prandial glycaemic surge. Incretins 
are naturally occurring hormones released by the gut. 
Upon entry of macronutrients in small intestine, these 
augment insulin secretion from beta cells of 
pancreas.This helps in control of post prandial rise of  
glucose. This mechanism is altered in uncontrolled 
diabetic patients due to delayed  gastric emptying.   
       Glycaemic response to meals is primarily 
controlled by delivery of  carbohydrates  into intestine 
 and the subsequent release of insulin in response to 
absorbed glucose. These mechanisms are subject to 
regulation by gut hormones and  neuro-transmitters. 1 
Gastrointestinal tract is recognised as the largest 
endocrine organ of the body. The term incretins 
characteristically defines gastro intestinal  hormones 
that act on pancreas to augment glucose dependant 
insulin secretion.2 Incretins also inhibit 
gluconeogenesis  by suppression of glucagon secretion 
 and regulate gastrointestinal motility  for controlled 
absorption of glucose  from gut.3  Incretins especially 
glucose dependant insulin trophic peptide (GIP) and 
glucagon like peptide (GIP-1) share the ability of 
controlling post prandial glucose excursion.4.Upon 
entry of macronutrients in duodenum ,incretins are 
released  from the gut.5 Gastric emptying time is 
significantly delayed in patients with diabetes . This 
may be due to hyperglycaemia or  diabetic autonomic  
neuropathy.6 In normal subjects as well as patients 
with diabetes the blood glucose response to oral 
carbohydrate as  well as rate of gastric  emptying are 
related . There is evidence that  modulation of gastric 
emptying by  dietary or pharmacological  means  can 
be used to optimise glycaemic control.7 In patients 
with  diabetic gastro paresis,  delayed food entry to the 
intestine may delay incretin release and thus  be a 
hindrance to post prandial glycaemic control.8 
 
Patients and Methods  
      This study was done in the diabetic clinic of 
Railway Hospital Rawalpindi. 180 patients with 
diabetes mellitus type2 and clinical features of nausea, 
anorexia, bloating and early satiety were included in 
the study where as patients with pregnancy, old age, 
malignancy, known APD and patients on steroids and 
NSAIDS were excluded from the study.Patients were 
randomly divided into two groups of ninety each. One 
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group(group 1,control group) was given usual oral 
anti-diabetic medications with placebo .The second 
group(group 2,study group) was also given their usual 
oral anti-diabetic medicines along with Domperidone 
10 mg, an oral prokinetic drug, in fasting state. Fasting 
blood sugar was  estimated. One hour later both 
groups were given identical breakfast. Two hours after 
the breakfast, blood glucose levels were again 
measured in both groups. Difference between fasting 
and  two hours post prandial blood sugars were 
compared between the two groups. 
 
Results 
      Out of one eighty patients included in the study, 
ages ranged from 39 years to sixty years with mean 
age of 52.67 years. Mean age in group 1 was 52.13 
years while in group 2 it was 53.15 years. Group 1 
included 44 males and 46 females. Group 2 included 
30 males and 60 females. Our analysis of data revealed 
that mean fasting blood sugar of group 1 was 168.57 
mg/dl and mean 2-hour postprandial sugar 296.73 
mg/dl. In group 2, mean fasting blood sugar was 
201.24 mg/dl and mean 2 hour postprandial sugar was 
296.42 mg/dl. Mean difference between two hour 
postprandial and fasting sugar in group 1 was 156.38 
mg/dl. While in group 2 mean difference between two 
hour postprandial and fasting blood sugar was 
114.15mg/dl(p=0.03 in both groups) 
Table 1: Comparison between diabetics 
with and without taking pro-kinetic drugs 
 Group-I (not 
taking 
prokinetic 
drugs) 
Group-II 
(taking 
prokinetic 
drugs) 
Total No of 
patients. 
90(50%) 90(50%) 
No of Male 
patients. 
44(48.8%) 30(33.3%) 
No of Female 
patients 
46(51.1%) 60(66.6%) 
Mean Age 52.13(SD 9.100) 53.15(SD 8.37) 
Mean Fasting 
Glucose Level 
(mg/dl) 
168.57(SD 
12.082) 
201.24(SD18.55
) 
Mean 2 Hours Post 
prandial Glucose 
Level (mg/dl) 
296.73(SD9.38) 296.42(SD9.29) 
Mean post prandial 
glycaemic Surge 
(mg/dl) 
156.38(SD 
10.04) 
114.15(SD 8.01) 
 
Discussion 
     Diabetes is a common clinical condition with 
substantial morbidity as well as mortality . The main 
goals of management   are early diagnosis and optimal 
glycaemic control to prevent long term complications.9 
Benefits  of  strict  glycaemic control are well 
documented in UKPDS study.10 Glycosylated  
haemoglobin levels are dependent on both pre and 
post prandial level . Post- prandial  levels of sugar play 
an active  role in determining HbA1c levels. Post-
prandial glucose excursions   are  affected by amount 
and nature of carbohydrate ingested, mechanical  
events  occurring and  hormones released by gut.11 
Potential causes of post prandial hyperglycaemia 
include increased absorption of dietary sugar, 
increased carbohydrate digestion, decreased insulin 
secretion, increased  glucagon or defects in glucose 
storage.12  
     Gastric emptying is delayed in majority of patients 
with type 2 diabetes.  “Incretin effect” describes the 
enhanced insulin response from orally ingested 
glucose compared with intra-venous glucose.13   
Gastro intestinal hormones promoting the incretin 
effect are called incretins . It contributes   to 60% of  the 
postprandial insulin secretion. It is diminished in type 
2 diabetes patients.14    
     Glucagon like peptide(GLP-1) is an important 
incretin secreted  by intestinal cells. Its secretion is 
dependent upon presence of nutrients in gut15,16. 
Addition of pro-kinetics before meal facilitates macro-
nutrient delivery to intestine optimising incretin 
secretion thus minimising post prandial glycaemic  
surge17. In present study addition of prokinetic in the 
study group showed better post parandial glycaemic 
control as compared to control group  This suggests 
that addition of pro-kinetics before food can help in 
limiting post –prandial blood sugar surge. We 
compared  results of our study with a study  done by  
Stevens JE et al . He studied the role of Itopride a pro-
kinetic  in improving  diabetic control and diabetic 
gastroparesis. In contrast to our observation he 
concluded that   glycaemic  control is not affected by 
be addition of  pro-kinetic like Itopride.. However  
analysis  of Stevens JE study shows that  all the  
patients enrolled  were insulin requiring  diabetics. 
Insulin is required in type2 diabetics when 
endogenous insulin secretion is diminished due to 
decrease in beta  cell mass This decreased beta cell 
mass might be responsible  for impaired response  to 
incretins even  when they are  adequately released  by 
enhanced food delivery to intestine. 
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Conclusion 
Augumenting the gastric motility by the use of 
prokinetics optimises incretin secretion and decreases 
the post prandial glycaemic surge. 
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